CYPB spreads wings, C solid, MOTR in reverse

Cypress Bioscience (NasdaqGM: CYPB) jumped 12.2% to$6.45, on volume of 8,570,704, or 16 times its full-day average, after it agreed to be acquired by Ramius LLC and Royalty Pharma for about $255 million in cash, ending a takeover battle that began in July.

Citigroup (NYSE: C) traded in 155,455,525 shares, making good headway on its daily average of 539,270,000 shares. Share prices retreated 0.53 per cent, however, Wednesday, to $4.66.

Motricity Inc. (NasdaqGM: MOTR) backtracked 13.53 percent in Wednesday morning trading at $18.40. Volume of 3,277,545 shares tramped its full-day average of 559,200. MOTR, based in Bellevue, Wash., is a leading mobile data solutions provider exclusively focused on the rapidly growing mobile Internet market.

Tags: biopharmaceuticals, Biotech Stocks, C, cypb, Financial Stocks, motr, nasdaq, NYSE, Technology Stocks

This entry was posted on Wednesday, December 15th, 2010 at 11:27 am by Glenn and is filed under Financial Stocks, pharmaceutical stocks, Technology Stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.